Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thioesterase superfamily member 7, pseudogene (THEM7P), also known as RP1-65P5.1, is a human pseudogene that is homologous to members of the thioesterase enzyme family but contains sequence alterations (such as frameshifts or premature stop codons) that prevent production of a functional protein[1][3][7][8]. It is not regarded as a functional receptor, enzyme, or therapeutic target. THEM7P does not encode a protein and does not have established biological function, molecular interactions, or disease associations specific to itself. Like many pseudogenes, it may theoretically participate in post-transcriptional gene regulation (for example, as a competing endogenous RNA or microRNA sponge), but no experimental evidence is presently available to confirm such a role for THEM7P[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thioesterase superfamily member 7, pseudogene (THEM7P).